Follow the ME Therapeutics Holdings Inc. stock price and the full insider trade history of the company, a publicly traded company based in Canada. Shares are listed on the CA market, under the oversight of SEDI. Market capitalisation: €26.4m. The latest transaction was filed on 16 July 2026 (53 - Grant of warrants). Among the most active insiders: Priatel, John. All data is openly available.
15
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
43Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
200 shares@ CA$1.99100.0% of flowCommon SharesTSXSEDI:4741838
Canonical exit: 27 Sept 2026 (T+90)
15 of 15 declarations
About ME Therapeutics Holdings Inc.
ME Therapeutics Holdings Inc. is a company listed on the Toronto Stock Exchange, specializing in the development of innovative therapies. It focuses on enhancing medical treatments through biotechnology-based approaches.